MDX-1185

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMDX-1185
Drug Alias Nameanti-interferon type I receptor antibody (Medarex/Corixa/Coulter/Pharma Pacific)64G12MDX-1185
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunosuppressantsInterferon receptor type I modulators
TargetsInterferon receptor type I
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Pacific Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoulter Pharmaceutical IncPharma Pacific Pty LtdCorixa Corp +[4] 
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A